Multimodal neuroimaging of alcohol use: from acute neurochemical effects to chronic brain network reorganization and precision treatment targets - Scorecard - MDSpire

Multimodal neuroimaging of alcohol use: from acute neurochemical effects to chronic brain network reorganization and precision treatment targets

  • By

  • Rodolfo Ferrando

  • May 11, 2026

  • 0 min

Share

Clinical Scorecard: Comprehensive Neuroimaging Approaches to Alcohol Consumption: Investigating Immediate Neurochemical Impacts, Long-term Brain Network Changes, and Targeted Treatment Strategies

At a Glance

CategoryDetail
ConditionAlcohol Use Disorder (AUD)
Key MechanismsNeurotoxic and neuroadaptive effects impacting multiple brain systems, including dopaminergic, GABAergic, glutamatergic, and opioid signaling.
Target PopulationIndividuals with alcohol use disorder, including adolescents and older adults.
Care SettingClinical and research settings utilizing multimodal neuroimaging techniques.

Key Highlights

  • Neuroimaging reveals acute and chronic effects of alcohol on brain structure and function.
  • Adolescent alcohol use is linked to deviations in brain maturation and increased vulnerability.
  • Longitudinal imaging can assess recovery during abstinence and predict clinical outcomes.
  • Distinct imaging patterns characterize neurological syndromes related to prolonged alcohol use.
  • Individual differences in brain structure and function correlate with AUD risk and treatment response.

Guideline-Based Recommendations

Diagnosis

  • Utilize structural MRI to detect neurological syndromes associated with alcohol use.

Management

  • Implement targeted treatment strategies based on neuroimaging markers of vulnerability.

Monitoring & Follow-up

  • Employ longitudinal imaging to monitor structural and functional recovery during abstinence.

Risks

  • Consider the impact of chronic alcohol exposure on brain atrophy and cognitive impairment.

Patient & Prescribing Data

Individuals diagnosed with alcohol use disorder, including those at familial or genetic risk.

Neuroimaging can inform treatment response and guide precision medicine approaches.

Clinical Best Practices

  • Integrate multimodal neuroimaging in the assessment and treatment of AUD.
  • Focus on individual differences in neuroimaging to tailor interventions.
  • Monitor neuroimaging markers to predict relapse and treatment outcomes.

Related Resources & Content

Original Source(s)

Related Content